3 hours Truist Financial Increases Verona Pharma (NASDAQ:VRNA) Price Target to $44.00 MarketBeat
Truist Financial upped their target price on Verona Pharma from $38.00 to $44.00 and gave the company a “buy” rating in a research note on Wednesday.
Nasdaq 100 · Science · Truist Financial Corp (TFC)